Press Releases

Today, a bipartisan group of 39 Senators -- led by Sens. Charles Grassley (R-IA), Amy Klobuchar (D-MN) -- urged EPA to get the Renewable Fuel Standard (RFS) “back on track by setting blending targets where Congress intended and by removing the…

Congress urged to “act immediately” to enact national programWashington, D.C. (June 23, 2016) – Senate leaders announced today an agreement on legislative language aimed at establishing national standards for GMO food labeling and disclosure. …

Bill would undermine critical work of biotechnology companies developing new cures and treatments.BIO SVP for Federal Government Relations released the following statement regarding H.R. 5573 and companion legislation in the Senate, which would…

Plan contains a number of promising proposals to protect patient access, foster medical innovation.Biotechnology Innovation Organization (BIO) President for Advocacy, Law and Public Policy Tom DiLenge released the following statement regarding the…

EPA’s new methodology for setting annual RFS volumes continues to chill investment in advanced biofuels, according to a new analysis released today. Investment patterns clearly demonstrate that EPA is sending a sustained market signal that…

Regrettably, today the Supreme Court missed an opportunity in the case of Cuozzo Speed Technologies, LLC v. Lee to reign in the United States Patent and Trademark Office’s Patent Trial and Appeal Board‘s invalidation of many patents under looser…

35,700 Partnering Meetings Held During the Convention15,937 Industry Leaders Attended World's Largest Biotech Gathering

BIO and Missouri Biotechnology Association (MOBIO) commend Governor Jay Nixon for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines. 

BIO today presented Virginia Governor Terry McAuliffe with its 2016 Governor of the Year award in recognition of his leadership and commitment to strengthening the biosciences industry within Virginia. Governor McAuliffe received the award at the…

 San Francisco, CA (June 8, 2016) – Today, the Biotechnology Innovation Organization (BIO) and Parent Project Muscular Dystrophy (PPMD) released a new report, “Key Considerations for Developing and Integrating Patient Perspectives in Drug…